Paul Hughes
Marietta, GANPI 1962943209
Payments from drug & device makers
$1,638in general payments, 2019–2025
Across 70 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$223
- Novartis$199
- AstraZeneca$140
- AbbVie$134
- Sanofi$107
- Regeneron Healthcare Solutions, Inc.$107
- plus $728 from 14 others
What the payments were for
- Food & beverage$1,638100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $223 |
| Novartis | 11 | $199 |
| AstraZeneca(2 entities) | 5 | $140 |
| AbbVie | 6 | $134 |
| Sanofi | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $101 |
| Amgen | 4 | $86 |
| Pfizer | 4 | $83 |
| Genentech, Inc. | 1 | $82 |
| GSK | 3 | $73 |
| Pharmacosmos Therapeutics Inc. | 2 | $72 |
| Genentech USA, Inc. | 3 | $68 |
| Syndax Pharmaceuticals, Inc. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
| Melinta Therapeutics, LLC | 1 | $22 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Octapharma USA, Inc. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $15 |
| La Jolla Pharmaceutical Company | 1 | $15 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.